Pricing Log in Create free account

DBV Technologies S.A. (DBVT) vs Geron Corporation (GERN)

DBV Technologies S.A. and Geron Corporation are both Biotechnology companies. DBV Technologies S.A. and Geron Corporation are of similar size ($615.8M and $610.4M). Geron Corporation grew revenue faster over the last twelve months: 18.6% against −33.4%. Geron Corporation has the higher net margin (−22.0% vs −5,547.3%) and the lower return on invested capital (−34.1% vs 0.00%). Across the 18 metrics below, Geron Corporation leads on 14 and DBV Technologies S.A. on 4.

Valuation

Metric DBVT GERN Biotechnology median
P/E n/m n/m 10.60
P/S 255.21 3.03 9.40
P/B 6.42 2.91 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 210.91 2.59 9.02
Earnings yield (29.23%) (7.49%) (32.88%)
Free cash flow yield (20.11%) (13.84%) (23.13%)

Profitability

Metric DBVT GERN Biotechnology median
Gross margin 100.00% 91.59% 68.51%
Operating margin (5,571.63%) (14.75%) 0.00%
Net margin (5,547.30%) (21.99%) 0.00%
Free cash flow margin (5,131.50%) (41.91%) 0.00%
Return on equity (205.75%) (20.12%) (51.96%)
Return on assets (127.19%) (8.74%) (46.06%)
Return on invested capital 0.00% (34.12%) 0.00%

Growth

Metric DBVT GERN Biotechnology median
Revenue growth (TTM) (33.42%) 18.60% 6.76%
EPS growth (last fiscal year) 10.26% 51.85% 29.88%
Revenue growth, 5-year CAGR (12.95%) 273.49% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DBVT GERN Biotechnology median
Debt to equity 0.00 0.53 0.00
Current ratio 3.24 6.31 4.97
Net debt to EBITDA 1.35 3.28 1.01

Dividend

Metric DBVT GERN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DBVT GERN Biotechnology median
Market cap 615.83m 610.41m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack